Department of Critical Care Medicine, Intensive Care Unit 1K12-C, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.
Expert Rev Anti Infect Ther. 2010 Mar;8(3):317-24. doi: 10.1586/eri.10.3.
Infectious complications in severe acute pancreatitis are an important problem and determine outcome in patients who survived the first inflammatory hit of the disease. Timely diagnosis of infected pancreatic necrosis is often challenging, but should not delay adequate treatment, which consists of source control and antibiotic treatment. Prophylactic antibiotics are not effective in reducing the incidence of (peri)pancreatic infection in patients with severe acute pancreatitis (or necrotizing pancreatitis). The only rational indication for antibiotics at this moment is documented infection. The spectrum of empiric antibiotics should cover both Gram-negative, Gram-positive and anaerobic microorganisms (also keeping in mind exposure to nosocomial microorganisms), and local ecology should be taken into account. Fungal infections are often present, and antifungal coverage should be considered, especially if multiple risk factors for invasive candidiasis are present. Currently, no tools are available to guide antimicrobial treatment.
严重急性胰腺炎的感染性并发症是一个重要问题,它决定了幸存患者的疾病首次炎症打击后的结局。感染性胰腺坏死的及时诊断常常具有挑战性,但不应延误充分的治疗,即包括源头控制和抗生素治疗。预防性抗生素并不能降低严重急性胰腺炎(或坏死性胰腺炎)患者(胰周)感染的发生率。此时使用抗生素的唯一合理指征是有明确的感染。经验性抗生素的谱应覆盖革兰阴性、革兰阳性和厌氧菌(同时考虑到医院获得性微生物),并应考虑局部生态。真菌感染很常见,应考虑覆盖抗真菌药物,尤其是如果存在多种侵袭性念珠菌病的危险因素。目前,尚无指导抗菌治疗的工具。